ContextVision is a medical technology software company that specializes in image analysis and artificial intelligence. ContextVision is the global market leader within image enhancement and is a software partner to leading medical imaging manufacturers all over the world. Its cutting-edge technology helps doctors accurately interpret medical images, a crucial foundation for better diagnosis and treatment.
Company overview
ContextVision is a global market leader within image enhancement and a software partner to the world’s most recognized medical imaging manufacturers.
The present multimodality product portfolio covers 2D/3D/4D Ultrasound, MRI, X-Ray and Mammography.
The present multimodality product portfolio covers 2D/3D/4D Ultrasound, MRI, X-Ray and Mammography.
As an industry pioneer for more than 30 years, ContextVision is taking a leading position within deep learning, the latest artificial intelligence technology, to broaden its product portfolio and enter a new rapidly growing market – digital pathology.
As an industry pioneer for more than 30 years within medical imaging, Contextvision entered growing digital pathology market with its first artificial intelligence based product for diagnosis of prostate cancer. Dedicated investments in R&D to expand the product portfolio with additional decision support tools for digital pathology continues.
ContextVision is based in Sweden, with local presentation in the U.S., Japan, China and Korea.
ContextVision is listed on the Oslo Stock Exchange under the ticker CONTX.